Veterinary Medicine Market is expected to reach US$ 50.89 Bn. at a CAGR of 7.10% during the forecast period 2029.Veterinary Medicine Market Dynamics
The MMR report includes various segments as well as an analysis of the trends and growth factors that are playing a substantial role in the market. These factors the market dynamics involve the drivers, restraints, opportunities, and challenges. Such as, The rise in the occurrence of contagious diseases among animals is driving the market for veterinary drugs. Animals also play a crucial role in research and development in studying drug therapy by performing preclinical trials in animals to develop advance drug and cost-effective veterinary drugs. Moreover, increasing awareness towards livestock and to cure zoonotic and chronic disease drives the market, rapid urbanization and an increase in per capita income drive the market growth.To know about the Research Methodology :- Request Free Sample Report However, the discovery of complex diseases and various infections in humans from animals through the consumption of animal products such as bird flu, bird flu, rabies, coronova virus, and others and not giving street animals appropriately treatment restraints the market growth. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Veterinary Medicine Market Opportunities:
Growing research and development investment to develop more effective drugs Rising meat consumption across the globe and animal-derived product like ghee, milk, butter give a better opportunity.Veterinary Medicine Market: Market Segment Analysis:
The report covers the brief analytical segments of the veterinary medicine market thereby providing a wider view at the macro as well as micro levels. By route of administration, parenteral is dominating the veterinary medicine market and valued around US$ xx Bn in 2022. Parenteral administration is more preferred over other as it gives rapid onset of action, The better bioavailability, and reliable dosage and it gives fast therapeutic effect with rapid onset of action as it overcomes the first-pass metabolism whereas, several adverse reactions and painful delivery and discomfort are the drawbacks and hinder the growth. Pharmacies & drug stores segment is projected to witness the fastest growth during the forecast period. Because of the requirement and urgency in clinical for targeted medicines and to protect from zoonotic diseases and livestock animals.Regional analysis:
North America’s Veterinary medicine market was valued at US$ xx million in 2022 and is expected to reach a value of US$ xx million by 2029, with a CAGR of xx%. The major factors which are driving the growth of the Veterinary medicine market in the regions as it provides good animal welfare policies and its spend huge expenditure on research in market especially the U.S and Canada. Since, North America is the developed region it consists of advance veterinary hospital and the large healthcare players and hence, take part in growing the economics of the market. Europe is considered the second most promising market after North America in the Advancement of new techniques and growing healthcare agencies the European market is undertaken by Germany and Frances and so, drives the European market.Veterinary Medicine Market Recent Development
In June 2018, Merck entered into a business with Vinovo B.V a division of Viscon Hatchery Automation. This has aided the company increase its portfolio of poultry vaccines. The objective of the report is to present a comprehensive analysis of the Global Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.Veterinary Medicine Market Scope : Inquire before buying
Global Veterinary Medicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 31.48 Bn. Forecast Period 2023 to 2029 CAGR: 7.10% Market Size in 2029: US $ 50.89 Bn. Segments Covered: by Product 1. Drugs 1.1. Anti-infectives 1.2. Anti-inflammatory 1.3. Parasiticides 2. Vaccines 2.1. Inactivated Vaccines 2.2. Attenuated Vaccines 2.3. Recombinant Vaccines 3. Medicated Feed Additives 3.1. Amino acids 3.2. Antibiotics by Route of Administration 1. Oral 2. Parenteral 3. Topical by Application 1. Companion Animals 2. Livestock Animals by End-User 1. Veterinary Hospital 2. Veterinary Clinics 3. Pharmacies & Drug Stores Veterinary Medicine Market, by Region:
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)key Players:
1. Agrovet Market Animal Health 2. American Veterinary Clinic 3. Animalcare 4. BASF India Ltd 5. Belfarmacom 6. Bimeda 7. Biotex Plus Ltd 8. Boehringer Ingelheim Gmbh 9. Brouwer 10. Cadila Pharmaceuticals Ltd 11. Cargill India Pvt. Ltd 12. Ceva 13. Chemo Argentina 14. Koninklijke DSM N.V 15. Mars 16. Merck & Co. 17. Saudi Pharmaceutical Industries 18. Sauvet 19. Selecta 20. Syntec 21. The British Veterinary Center 22. UCBVET 23. Vetanco 24. Veterinarski Zavod Subotica 25. Vetmedica 26. Wageningen Bioveterinary Research 27. Wilbur-Ellis 28. ZoetisFrequently Asked Questions:
1. Which region has the largest share in Global Veterinary Medicine Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Veterinary Medicine Market? Ans: The Global Veterinary Medicine Market is expected to grow at a CAGR of 7.10% during forecast period 2023-2029. 3. What is scope of the Global Veterinary Medicine market report? Ans: Global Veterinary Medicine Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Veterinary Medicine market? Ans: The important key players in the Global Veterinary Medicine Market are – Agrovet Market Animal Health, American Veterinary Clinic, Animalcare, BASF India Ltd, Belfarmacom, Bimeda, Biotex Plus Ltd, Boehringer Ingelheim Gmbh, Brouwer, Cadila Pharmaceuticals Ltd, Cargill India Pvt. Ltd, Ceva, Chemo Argentina, Koninklijke DSM N.V, Mars, Merck & Co., Saudi Pharmaceutical Industries, Sauvet, Selecta, Syntec, The British Veterinary Center, UCBVET, Vetanco, Veterinarski Zavod Subotica, Vetmedica, Wageningen Bioveterinary Research, Wilbur-Ellis, and Zoetis 5. What is the study period of this market? Ans: The Global Veterinary Medicine Market is studied from 2022 to 2029.
Global Veterinary Medicine Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Veterinary Medicine Market Size, by Market Value (US$ Bn) & Volume (Unit) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Veterinary Medicine Market Analysis and Forecast 6.1. Global Veterinary Medicine Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Veterinary Medicine Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Veterinary Medicine Market Value Share Analysis, By Product 7.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Product 7.5. Global Veterinary Medicine Market Analysis, By Product 7.6. Global Veterinary Medicine Market Attractiveness Analysis, By Product 8. Global Veterinary Medicine Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Veterinary Medicine Market Value Share Analysis, By Route of Administration 8.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Route of Administration 8.5. Global Veterinary Medicine Market Analysis, By Route of Administration 8.6. Global Veterinary Medicine Market Attractiveness Analysis, By Route of Administration 9. Global Veterinary Medicine Market Analysis and Forecast, By End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Veterinary Medicine Market Value Share Analysis, By End-User 9.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By End-User 9.5. Global Veterinary Medicine Market Analysis, By End-User 9.6. Global Veterinary Medicine Market Attractiveness Analysis, By End-User 10. Global Veterinary Medicine Market Analysis and Forecast, By Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Veterinary Medicine Market Value Share Analysis, By Application 10.4. Global Veterinary Medicine Market Size (US$ Bn) Forecast, By Application 10.5. Global Veterinary Medicine Market Analysis, By Application 10.6. Global Veterinary Medicine Market Attractiveness Analysis, By Application 11. Global Veterinary Medicine Market Analysis, by Region 11.1. Global Veterinary Medicine Market Value Share Analysis, by Region 11.2. Global Veterinary Medicine Market Size (US$ Bn) Forecast, by Region 11.3. Global Veterinary Medicine Market Attractiveness Analysis, by Region 12. North America Veterinary Medicine Market Analysis 12.1. Key Findings 12.2. North America Veterinary Medicine Market Overview 12.3. North America Veterinary Medicine Market Value Share Analysis, By Product 12.4. North America Veterinary Medicine Market Forecast, By Product 12.4.1. Drugs 12.4.1.1. Anti-infectives 12.4.1.2. Anti-inflammatory 12.4.1.3. Parasiticides 12.4.2. Vaccines 12.4.2.1. Inactivated Vaccines 12.4.2.2. Attenuated Vaccines 12.4.2.3. Recombinant Vaccines 12.4.3. Medicated Feed Additives 12.4.3.1. Amino acids 12.4.3.2. Antibiotics 12.5. North America Veterinary Medicine Market Value Share Analysis, By Route of Administration 12.6. North America Veterinary Medicine Market Forecast, By Route of Administration 12.6.1. Oral 12.6.2. Parenteral 12.6.3. Topical 12.7. North America Veterinary Medicine Market Value Share Analysis, By End-User 12.8. North America Veterinary Medicine Market Forecast, By End-User 12.8.1. Veterinary Hospital 12.8.2. Veterinary Clinics 12.8.3. Pharmacies & Drug Stores 12.9. North America Veterinary Medicine Market Value Share Analysis, By Application 12.10. North America Veterinary Medicine Market Forecast, By Application 12.10.1. Companion Animals 12.10.2. Livestock Animals 12.11. North America Veterinary Medicine Market Value Share Analysis, by Country 12.12. North America Veterinary Medicine Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Veterinary Medicine Market Analysis, by Country 12.14. U.S. Veterinary Medicine Market Forecast, By Product 12.14.1. Drugs 12.14.1.1. Anti-infectives 12.14.1.2. Anti-inflammatory 12.14.1.3. Parasiticides 12.14.2. Vaccines 12.14.2.1. Inactivated Vaccines 12.14.2.2. Attenuated Vaccines 12.14.2.3. Recombinant Vaccines 12.14.3. Medicated Feed Additives 12.14.3.1. Amino acids 12.14.3.2. Antibiotics 12.15. U.S. Veterinary Medicine Market Forecast, By Route of Administration 12.15.1. Oral 12.15.2. Parenteral 12.15.3. Topical 12.16. U.S. Veterinary Medicine Market Forecast, By End-User 12.16.1. Veterinary Hospital 12.16.2. Veterinary Clinics 12.16.3. Pharmacies & Drug Stores 12.17. U.S. Veterinary Medicine Market Forecast, By Application 12.17.1. Companion Animals 12.17.2. Livestock Animals 12.18. Canada Veterinary Medicine Market Forecast, By Product 12.18.1. Drugs 12.18.1.1. Anti-infectives 12.18.1.2. Anti-inflammatory 12.18.1.3. Parasiticides 12.18.2. Vaccines 12.18.2.1. Inactivated Vaccines 12.18.2.2. Attenuated Vaccines 12.18.2.3. Recombinant Vaccines 12.18.3. Medicated Feed Additives 12.18.3.1. Amino acids 12.18.3.2. Antibiotics 12.19. Canada Veterinary Medicine Market Forecast, By Route of Administration 12.19.1. Oral 12.19.2. Parenteral 12.19.3. Topical 12.20. Canada Veterinary Medicine Market Forecast, By End-User 12.20.1. Veterinary Hospital 12.20.2. Veterinary Clinics 12.20.3. Pharmacies & Drug Stores 12.21. Canada Veterinary Medicine Market Forecast, By Application 12.21.1. Companion Animals 12.21.2. Livestock Animals 12.22. North America Veterinary Medicine Market Attractiveness Analysis 12.22. North America Veterinary Medicine Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By Route of Administration 12.22.3. By End-User 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Veterinary Medicine Market Analysis 13.1. Key Findings 13.2. Europe Veterinary Medicine Market Overview 13.3. Europe Veterinary Medicine Market Value Share Analysis, By Product 13.4. Europe Veterinary Medicine Market Forecast, By Product 13.4.1. Drugs 13.4.1.1. Anti-infectives 13.4.1.2. Anti-inflammatory 13.4.1.3. Parasiticides 13.4.2. Vaccines 13.4.2.1. Inactivated Vaccines 13.4.2.2. Attenuated Vaccines 13.4.2.3. Recombinant Vaccines 13.4.3. Medicated Feed Additives 13.4.3.1. Amino acids 13.4.3.2. Antibiotics 13.5. Europe Veterinary Medicine Market Value Share Analysis, By Route of Administration 13.6. Europe Veterinary Medicine Market Forecast, By Route of Administration 13.6.1. Oral 13.6.2. Parenteral 13.6.3. Topical 13.7. Europe Veterinary Medicine Market Value Share Analysis, By End-User 13.8. Europe Veterinary Medicine Market Forecast, By End-User 13.8.1. Veterinary Hospital 13.8.2. Veterinary Clinics 13.8.3. Pharmacies & Drug Stores 13.9. Europe Veterinary Medicine Market Value Share Analysis, By Application 13.10. Europe Veterinary Medicine Market Forecast, By Application 13.10.1. Companion Animals 13.10.2. Livestock Animals 13.11. Europe Veterinary Medicine Market Value Share Analysis, by Country 13.12. Europe Veterinary Medicine Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Veterinary Medicine Market Analysis, by Country 13.14. Germany Veterinary Medicine Market Forecast, By Product 13.14.1. Drugs 13.14.1.1. Anti-infectives 13.14.1.2. Anti-inflammatory 13.14.1.3. Parasiticides 13.14.2. Vaccines 13.14.2.1. Inactivated Vaccines 13.14.2.2. Attenuated Vaccines 13.14.2.3. Recombinant Vaccines 13.14.3. Medicated Feed Additives 13.14.3.1. Amino acids 13.14.3.2. Antibiotics 13.15. Germany Veterinary Medicine Market Forecast, By Route of Administration 13.15.1. Oral 13.15.2. Parenteral 13.15.3. Topical 13.16. Germany Veterinary Medicine Market Forecast, By End-User 13.16.1. Veterinary Hospital 13.16.2. Veterinary Clinics 13.16.3. Pharmacies & Drug Stores 13.17. Germany Veterinary Medicine Market Forecast, By Application 13.17.1. Companion Animals 13.17.2. Livestock Animals 13.18. U.K. Veterinary Medicine Market Forecast, By Product 13.18.1. Drugs 13.18.1.1. Anti-infectives 13.18.1.2. Anti-inflammatory 13.18.1.3. Parasiticides 13.18.2. Vaccines 13.18.2.1. Inactivated Vaccines 13.18.2.2. Attenuated Vaccines 13.18.2.3. Recombinant Vaccines 13.18.3. Medicated Feed Additives 13.18.3.1. Amino acids 13.18.3.2. Antibiotics 13.19. U.K. Veterinary Medicine Market Forecast, By Route of Administration 13.19.1. Oral 13.19.2. Parenteral 13.19.3. Topical 13.20. U.K. Veterinary Medicine Market Forecast, By End-User 13.20.1. Veterinary Hospital 13.20.2. Veterinary Clinics 13.20.3. Pharmacies & Drug Stores 13.21. U.K. Veterinary Medicine Market Forecast, By Application 13.21.1. Companion Animals 13.21.2. Livestock Animals 13.22. France Veterinary Medicine Market Forecast, By Product 13.22.1. Drugs 13.22.1.1. Anti-infectives 13.22.1.2. Anti-inflammatory 13.22.1.3. Parasiticides 13.22.2. Vaccines 13.22.2.1. Inactivated Vaccines 13.22.2.2. Attenuated Vaccines 13.22.2.3. Recombinant Vaccines 13.22.3. Medicated Feed Additives 13.22.3.1. Amino acids 13.22.3.2. Antibiotics 13.23. France Veterinary Medicine Market Forecast, By Route of Administration 13.23.1. Oral 13.23.2. Parenteral 13.23.3. Topical 13.24. France Veterinary Medicine Market Forecast, By End-User 13.24.1. Veterinary Hospital 13.24.2. Veterinary Clinics 13.24.3. Pharmacies & Drug Stores 13.25. France Veterinary Medicine Market Forecast, By Application 13.25.1. Companion Animals 13.25.2. Livestock Animals 13.26. Italy Veterinary Medicine Market Forecast, By Product 13.26.1. Drugs 13.26.1.1. Anti-infectives 13.26.1.2. Anti-inflammatory 13.26.1.3. Parasiticides 13.26.2. Vaccines 13.26.2.1. Inactivated Vaccines 13.26.2.2. Attenuated Vaccines 13.26.2.3. Recombinant Vaccines 13.26.3. Medicated Feed Additives 13.26.3.1. Amino acids 13.26.3.2. Antibiotics 13.27. Italy Veterinary Medicine Market Forecast, By Route of Administration 13.27.1. Oral 13.27.2. Parenteral 13.27.3. Topical 13.28. Italy Veterinary Medicine Market Forecast, By End-User 13.28.1. Veterinary Hospital 13.28.2. Veterinary Clinics 13.28.3. Pharmacies & Drug Stores 13.29. Italy Veterinary Medicine Market Forecast, By Application 13.29.1. Companion Animals 13.29.2. Livestock Animals 13.30. Spain Veterinary Medicine Market Forecast, By Product 13.30.1. Drugs 13.30.1.1. Anti-infectives 13.30.1.2. Anti-inflammatory 13.30.1.3. Parasiticides 13.30.2. Vaccines 13.30.2.1. Inactivated Vaccines 13.30.2.2. Attenuated Vaccines 13.30.2.3. Recombinant Vaccines 13.30.3. Medicated Feed Additives 13.30.3.1. Amino acids 13.30.3.2. Antibiotics 13.31. Spain Veterinary Medicine Market Forecast, By Route of Administration 13.31.1. Oral 13.31.2. Parenteral 13.31.3. Topical 13.32. Spain Veterinary Medicine Market Forecast, By End-User 13.32.1. Veterinary Hospital 13.32.2. Veterinary Clinics 13.32.3. Pharmacies & Drug Stores 13.33. Spain Veterinary Medicine Market Forecast, By Application 13.33.1. Companion Animals 13.33.2. Livestock Animals 13.34. Rest of Europe Veterinary Medicine Market Forecast, By Product 13.34.1. Drugs 13.34.1.1. Anti-infectives 13.34.1.2. Anti-inflammatory 13.34.1.3. Parasiticides 13.34.2. Vaccines 13.34.2.1. Inactivated Vaccines 13.34.2.2. Attenuated Vaccines 13.34.2.3. Recombinant Vaccines 13.34.3. Medicated Feed Additives 13.34.3.1. Amino acids 13.34.3.2. Antibiotics 13.35. Rest of Europe Veterinary Medicine Market Forecast, By Route of Administration 13.35.1. Oral 13.35.2. Parenteral 13.35.3. Topical 13.36. Rest of Europe Veterinary Medicine Market Forecast, By End-User 13.36.1. Veterinary Hospital 13.36.2. Veterinary Clinics 13.36.3. Pharmacies & Drug Stores 13.37. Rest Of Europe Veterinary Medicine Market Forecast, By Application 13.37.1. Companion Animals 13.37.2. Livestock Animals 13.38. Europe Veterinary Medicine Market Attractiveness Analysis 13.38.1. By Product 13.38.2. By Route of Administration 13.38.3. By End-User 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Veterinary Medicine Market Analysis 14.1. Key Findings 14.2. Asia Pacific Veterinary Medicine Market Overview 14.3. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Product 14.4. Asia Pacific Veterinary Medicine Market Forecast, By Product 14.4.1. Drugs 14.4.1.1. Anti-infectives 14.4.1.2. Anti-inflammatory 14.4.1.3. Parasiticides 14.4.2. Vaccines 14.4.2.1. Inactivated Vaccines 14.4.2.2. Attenuated Vaccines 14.4.2.3. Recombinant Vaccines 14.4.3. Medicated Feed Additives 14.4.3.1. Amino acids 14.4.3.2. Antibiotics 14.5. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Route of Administration 14.6. Asia Pacific Veterinary Medicine Market Forecast, By Route of Administration 14.6.1. Oral 14.6.2. Parenteral 14.6.3. Topical 14.7. Asia Pacific Veterinary Medicine Market Value Share Analysis, By End-User 14.8. Asia Pacific Veterinary Medicine Market Forecast, By End-User 14.8.1. Veterinary Hospital 14.8.2. Veterinary Clinics 14.8.3. Pharmacies & Drug Stores 14.9. Asia Pacific Veterinary Medicine Market Value Share Analysis, By Application 14.10. Asia Pacific Veterinary Medicine Market Forecast, By Application 14.10.1. Companion Animals 14.10.2. Livestock Animals 14.11. Asia Pacific Veterinary Medicine Market Value Share Analysis, by Country 14.12. Asia Pacific Veterinary Medicine Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Veterinary Medicine Market Analysis, by Country 14.14. China Veterinary Medicine Market Forecast, By Product 14.14.1. Drugs 14.14.1.1. Anti-infectives 14.14.1.2. Anti-inflammatory 14.14.1.3. Parasiticides 14.14.2. Vaccines 14.14.2.1. Inactivated Vaccines 14.14.2.2. Attenuated Vaccines 14.14.2.3. Recombinant Vaccines 14.14.3. Medicated Feed Additives 14.14.3.1. Amino acids 14.14.3.2. Antibiotics 14.15. China Veterinary Medicine Market Forecast, By Route of Administration 14.15.1. Oral 14.15.2. Parenteral 14.15.3. Topical 14.16. China Veterinary Medicine Market Forecast, By End-User 14.16.1. Veterinary Hospital 14.16.2. Veterinary Clinics 14.16.3. Pharmacies & Drug Stores 14.17. China Veterinary Medicine Market Forecast, By Application 14.17.1. Companion Animals 14.17.2. Livestock Animals 14.18. India Veterinary Medicine Market Forecast, By Product 14.18.1. Drugs 14.18.1.1. Anti-infectives 14.18.1.2. Anti-inflammatory 14.18.1.3. Parasiticides 14.18.2. Vaccines 14.18.2.1. Inactivated Vaccines 14.18.2.2. Attenuated Vaccines 14.18.2.3. Recombinant Vaccines 14.18.3. Medicated Feed Additives 14.18.3.1. Amino acids 14.18.3.2. Antibiotics 14.19. India Veterinary Medicine Market Forecast, By Route of Administration 14.19.1. Oral 14.19.2. Parenteral 14.19.3. Topical 14.20. India Veterinary Medicine Market Forecast, By End-User 14.20.1. Veterinary Hospital 14.20.2. Veterinary Clinics 14.20.3. Pharmacies & Drug Stores 14.21. India Veterinary Medicine Market Forecast, By Application 14.21.1. Companion Animals 14.21.2. Livestock Animals 14.22. Japan Veterinary Medicine Market Forecast, By Product 14.22.1. Drugs 14.22.1.1. Anti-infectives 14.22.1.2. Anti-inflammatory 14.22.1.3. Parasiticides 14.22.2. Vaccines 14.22.2.1. Inactivated Vaccines 14.22.2.2. Attenuated Vaccines 14.22.2.3. Recombinant Vaccines 14.22.3. Medicated Feed Additives 14.22.3.1. Amino acids 14.22.3.2. Antibiotics 14.23. Japan Veterinary Medicine Market Forecast, By Route of Administration 14.23.1. Oral 14.23.2. Parenteral 14.23.3. Topical 14.24. Japan Veterinary Medicine Market Forecast, By End-User 14.24.1. Veterinary Hospital 14.24.2. Veterinary Clinics 14.24.3. Pharmacies & Drug Stores 14.25. Japan Veterinary Medicine Market Forecast, By Application 14.25.1. Companion Animals 14.25.2. Livestock Animals 14.26. ASEAN Veterinary Medicine Market Forecast, By Product 14.26.1. Drugs 14.26.1.1. Anti-infectives 14.26.1.2. Anti-inflammatory 14.26.1.3. Parasiticides 14.26.2. Vaccines 14.26.2.1. Inactivated Vaccines 14.26.2.2. Attenuated Vaccines 14.26.2.3. Recombinant Vaccines 14.26.3. Medicated Feed Additives 14.26.3.1. Amino acids 14.26.3.2. Antibiotics 14.27. ASEAN Veterinary Medicine Market Forecast, By Route of Administration 14.27.1. Oral 14.27.2. Parenteral 14.27.3. Topical 14.28. ASEAN Veterinary Medicine Market Forecast, By End-User 14.28.1. Veterinary Hospital 14.28.2. Veterinary Clinics 14.28.3. Pharmacies & Drug Stores 14.29. ASEAN Veterinary Medicine Market Forecast, By Application 14.29.1. Companion Animals 14.29.2. Livestock Animals 14.30. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Product 14.30.1. Drugs 14.30.1.1. Anti-infectives 14.30.1.2. Anti-inflammatory 14.30.1.3. Parasiticides 14.30.2. Vaccines 14.30.2.1. Inactivated Vaccines 14.30.2.2. Attenuated Vaccines 14.30.2.3. Recombinant Vaccines 14.30.3. Medicated Feed Additives 14.30.3.1. Amino acids 14.30.3.2. Antibiotics 14.31. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Route of Administration 14.31.1. Oral 14.31.2. Parenteral 14.31.3. Topical 14.32. Rest of Asia Pacific Veterinary Medicine Market Forecast, By End-User 14.32.1. Veterinary Hospital 14.32.2. Veterinary Clinics 14.32.3. Pharmacies & Drug Stores 14.33. Rest of Asia Pacific Veterinary Medicine Market Forecast, By Application 14.33.1. Companion Animals 14.33.2. Livestock Animals 14.34. Asia Pacific Veterinary Medicine Market Attractiveness Analysis 14.34.1. By Product 14.34.2. By Route of Administration 14.34.3. By End-User 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Veterinary Medicine Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Veterinary Medicine Market Overview 15.3. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Product 15.4. Middle East & Africa Veterinary Medicine Market Forecast, By Product 15.4.1. Drugs 15.4.1.1. Anti-infectives 15.4.1.2. Anti-inflammatory 15.4.1.3. Parasiticides 15.4.2. Vaccines 15.4.2.1. Inactivated Vaccines 15.4.2.2. Attenuated Vaccines 15.4.2.3. Recombinant Vaccines 15.4.3. Medicated Feed Additives 15.4.3.1. Amino acids 15.4.3.2. Antibiotics 15.5. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Route of Administration 15.6. Middle East & Africa Veterinary Medicine Market Forecast, By Route of Administration 15.6.1. Oral 15.6.2. Parenteral 15.6.3. Topical 15.7. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By End-User 15.8. Middle East & Africa Veterinary Medicine Market Forecast, By End-User 15.8.1. Veterinary Hospital 15.8.2. Veterinary Clinics 15.8.3. Pharmacies & Drug Stores 15.9. Middle East & Africa Veterinary Medicine Market Value Share Analysis, By Application 15.10. Middle East & Africa Veterinary Medicine Market Forecast, By Application 15.10.1. Companion Animals 15.10.2. Livestock Animals 15.11. Middle East & Africa Veterinary Medicine Market Value Share Analysis, by Country 15.12. Middle East & Africa Veterinary Medicine Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Veterinary Medicine Market Analysis, by Country 15.14. GCC Veterinary Medicine Market Forecast, By Product 15.14.1. Drugs 15.14.1.1. Anti-infectives 15.14.1.2. Anti-inflammatory 15.14.1.3. Parasiticides 15.14.2. Vaccines 15.14.2.1. Inactivated Vaccines 15.14.2.2. Attenuated Vaccines 15.14.2.3. Recombinant Vaccines 15.14.3. Medicated Feed Additives 15.14.3.1. Amino acids 15.14.3.2. Antibiotics 15.15. GCC Veterinary Medicine Market Forecast, By Route of Administration 15.15.1. Oral 15.15.2. Parenteral 15.15.3. Topical 15.16. GCC Veterinary Medicine Market Forecast, By End-User 15.16.1. Veterinary Hospital 15.16.2. Veterinary Clinics 15.16.3. Pharmacies & Drug Stores 15.17. GCC Veterinary Medicine Market Forecast, By Application 15.17.1. Companion Animals 15.17.2. Livestock Animals 15.18. South Africa Veterinary Medicine Market Forecast, By Product 15.18.1. Drugs 15.18.1.1. Anti-infectives 15.18.1.2. Anti-inflammatory 15.18.1.3. Parasiticides 15.18.2. Vaccines 15.18.2.1. Inactivated Vaccines 15.18.2.2. Attenuated Vaccines 15.18.2.3. Recombinant Vaccines 15.18.3. Medicated Feed Additives 15.18.3.1. Amino acids 15.18.3.2. Antibiotics 15.19. South Africa Veterinary Medicine Market Forecast, By Route of Administration 15.19.1. Oral 15.19.2. Parenteral 15.19.3. Topical 15.20. South Africa Veterinary Medicine Market Forecast, By End-User 15.20.1. Veterinary Hospital 15.20.2. Veterinary Clinics 15.20.3. Pharmacies & Drug Stores 15.21. South Africa Veterinary Medicine Market Forecast, By Application 15.21.1. Companion Animals 15.21.2. Livestock Animals 15.22. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Product 15.22.1. Drugs 15.22.1.1. Anti-infectives 15.22.1.2. Anti-inflammatory 15.22.1.3. Parasiticides 15.22.2. Vaccines 15.22.2.1. Inactivated Vaccines 15.22.2.2. Attenuated Vaccines 15.22.2.3. Recombinant Vaccines 15.22.3. Medicated Feed Additives 15.22.3.1. Amino acids 15.22.3.2. Antibiotics 15.23. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Route of Administration 15.23.1. Oral 15.23.2. Parenteral 15.23.3. Topical 15.24. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By End-User 15.24.1. Veterinary Hospital 15.24.2. Veterinary Clinics 15.24.3. Pharmacies & Drug Stores 15.25. Rest of Middle East & Africa Veterinary Medicine Market Forecast, By Application 15.25.1. Companion Animals 15.25.2. Livestock Animals 15.26. Middle East & Africa Veterinary Medicine Market Attractiveness Analysis 15.26.1. By Product 15.26.2. By Route of Administration 15.26.3. By End-User 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Veterinary Medicine Market Analysis 16.1. Key Findings 16.2. South America Veterinary Medicine Market Overview 16.3. South America Veterinary Medicine Market Value Share Analysis, By Product 16.4. South America Veterinary Medicine Market Forecast, By Product 16.4.1. Drugs 16.4.1.1. Anti-infectives 16.4.1.2. Anti-inflammatory 16.4.1.3. Parasiticides 16.4.2. Vaccines 16.4.2.1. Inactivated Vaccines 16.4.2.2. Attenuated Vaccines 16.4.2.3. Recombinant Vaccines 16.4.3. Medicated Feed Additives 16.4.3.1. Amino acids 16.4.3.2. Antibiotics 16.5. South America Veterinary Medicine Market Value Share Analysis, By Route of Administration 16.6. South America Veterinary Medicine Market Forecast, By Route of Administration 16.6.1. Oral 16.6.2. Parenteral 16.6.3. Topical 16.7. South America Veterinary Medicine Market Value Share Analysis, By End-User 16.8. South America Veterinary Medicine Market Forecast, By End-User 16.8.1. Veterinary Hospital 16.8.2. Veterinary Clinics 16.8.3. Pharmacies & Drug Stores 16.9. South America Veterinary Medicine Market Value Share Analysis, By Application 16.10. South America Veterinary Medicine Market Forecast, By Application 16.10.1. Companion Animals 16.10.2. Livestock Animals 16.11. South America Veterinary Medicine Market Value Share Analysis, by Country 16.12. South America Veterinary Medicine Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Veterinary Medicine Market Analysis, by Country 16.14. Brazil Veterinary Medicine Market Forecast, By Product 16.14.1. Drugs 16.14.1.1. Anti-infectives 16.14.1.2. Anti-inflammatory 16.14.1.3. Parasiticides 16.14.2. Vaccines 16.14.2.1. Inactivated Vaccines 16.14.2.2. Attenuated Vaccines 16.14.2.3. Recombinant Vaccines 16.14.3. Medicated Feed Additives 16.14.3.1. Amino acids 16.14.3.2. Antibiotics 16.15. Brazil Veterinary Medicine Market Forecast, By Route of Administration 16.15.1. Oral 16.15.2. Parenteral 16.15.3. Topical 16.16. Brazil Veterinary Medicine Market Forecast, By End-User 16.16.1. Veterinary Hospital 16.16.2. Veterinary Clinics 16.16.3. Pharmacies & Drug Stores 16.17. Brazil Veterinary Medicine Market Forecast, By Application 16.17.1. Companion Animals 16.17.2. Livestock Animals 16.18. Mexico Veterinary Medicine Market Forecast, By Product 16.18.1. Drugs 16.18.1.1. Anti-infectives 16.18.1.2. Anti-inflammatory 16.18.1.3. Parasiticides 16.18.2. Vaccines 16.18.2.1. Inactivated Vaccines 16.18.2.2. Attenuated Vaccines 16.18.2.3. Recombinant Vaccines 16.18.3. Medicated Feed Additives 16.18.3.1. Amino acids 16.18.3.2. Antibiotics 16.19. Mexico Veterinary Medicine Market Forecast, By Route of Administration 16.19.1. Oral 16.19.2. Parenteral 16.19.3. Topical 16.20. Mexico Veterinary Medicine Market Forecast, By End-User 16.20.1. Veterinary Hospital 16.20.2. Veterinary Clinics 16.20.3. Pharmacies & Drug Stores 16.21. Mexico Veterinary Medicine Market Forecast, By Application 16.21.1. Companion Animals 16.21.2. Livestock Animals 16.22. Rest of South America Veterinary Medicine Market Forecast, By Product 16.22.1. Drugs 16.22.1.1. Anti-infectives 16.22.1.2. Anti-inflammatory 16.22.1.3. Parasiticides 16.22.2. Vaccines 16.22.2.1. Inactivated Vaccines 16.22.2.2. Attenuated Vaccines 16.22.2.3. Recombinant Vaccines 16.22.3. Medicated Feed Additives 16.22.3.1. Amino acids 16.22.3.2. Antibiotics 16.23. Rest of South America Veterinary Medicine Market Forecast, By Route of Administration 16.23.1. Oral 16.23.2. Parenteral 16.23.3. Topical 16.24. Rest of South America Veterinary Medicine Market Forecast, By End-User 16.24.1. Veterinary Hospital 16.24.2. Veterinary Clinics 16.24.3. Pharmacies & Drug Stores 16.25. Rest of South America Veterinary Medicine Market Forecast, By Application 16.25.1. Companion Animals 16.25.2. Livestock Animals 16.26. South America Veterinary Medicine Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By Route of Administration 16.26.3. By End-User 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Agrovet Market Animal Health 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. American Veterinary Clinic 17.3.3. Animalcare 17.3.4. BASF India Ltd 17.3.5. Belfarmacom 17.3.6. Bimeda 17.3.7. Biotex Plus Ltd 17.3.8. Boehringer Ingelheim Gmbh 17.3.9. Brouwer 17.3.10. Cadila Pharmaceuticals Ltd 17.3.11. Cargill India Pvt. Ltd 17.3.12. Ceva 17.3.13. Chemo Argentina 17.3.14. Koninklijke DSM N.V 17.3.15. Mars 17.3.16. Merck & Co. 17.3.17. Saudi Pharmaceutical Industries 17.3.18. Sauvet 17.3.19. Selecta 17.3.20. Syntec 17.3.21. The British Veterinary Center 17.3.22. UCBVET 17.3.23. Vetanco 17.3.24. Veterinarski Zavod Subotica 17.3.25. Vetmedica 17.3.26. Wageningen Bioveterinary Research 17.3.27. Wilbur-Ellis 17.3.28. Zoetis 18. Primary Key Insights